WHO ICTRP trial
EUCTR2005-005631-97-IT · ISTITUTO NAZIONALE PER LO STUDIO E LA CURA DEI TUMORI - FONDAZIONE "G. PASCALE"
EUCTR2005-005631-97-IT · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2005-005631-97-IT |
|---|---|
| Scientific title | N/A - CAPPA-2 (PS-2) |
| Primary sponsor | ISTITUTO NAZIONALE PER LO STUDIO E LA CURA DEI TUMORI - FONDAZIONE "G. PASCALE" |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): yes Therapeutic use (Phase IV): no |
| Countries | Italy |
| Conditions | MedDRA version: 6.1 Level: PT Classification code 10059515 |
| Interventions | Trade Name: GEMZAR*INFUS 1FL 1G POLV Pharmaceutical Form: Powder and solvent for solution for infusion INN or Proposed INN: Gemcitabine Concentration unit: g gram(s) Concentration type: equal Concentration number: 1- Pharmaceutical Form… |
| Registration date | Jul 17, 2007 |
| Target size | 360 |
| Secondary IDs | CAPPA-2 (PS-2) |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: